ReviewJournal of hepatocellular carcinoma2024

CRISPR in Targeted Therapy and Adoptive T Cell Immunotherapy for Hepatocellular Carcinoma.

Fahreddin Palaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.